Accelerate to discover

Homepage>Discover>The ThunderBolts myeloid NGS panel: a translational laboratory experience

Dec 28, 2020

Radio-active sources have been used routinely for the preconditioning in humanized mouse models, but safety issues have...

EV imaging series: Using ONI super-resolution to characterize single-EVs

Dec 23, 2020

To date, researchers commonly use flow-based characterization methods, fluorescence imaging techniques and electron...

Don’t Let Waste Anesthetic Gases Harm You!

Dec 21, 2020

Many projects have been devoted to the study of the correlation between anesthetics and Alzheimer’s disease....

Advances in Leukemia research using shear flow and Bioflux system

Dec 10, 2020

Leukemia is a rare cancer with many subtypes. The production of abnormal leukocytes create disruptions in the immune...

Dec 30, 2020

Dosimetric characterization of an X-ray irradiator for use with cells

Dec 4, 2020

This study aims to characterize an X-ray irradiator for use with cells using its internal parallel-plate ionization...

Modeling multiple myeloma-Bone Marrow interactions using Synthecon rotating-wall vessels

Dec 2, 2020

Multiple myeloma develops primarily inside the bone marrow microenvironment, that confers pro-survival signals and drug...

Bruker webinar: Ear evolution in fossil mammals

Nov 27, 2020

Hearing is just one of the functions aside of providing balance. Even juveniles obtain a fully developed ear region...

Dec 30, 2020

ONI Nanoimager joins the fight against COVID-19

Nov 24, 2020

ONI is supporting the global effort into research and diagnostics to tackle the COVID-19 pandemic. ONI is currently...

Show all topics (10)

The ThunderBolts myeloid NGS panel: a translational laboratory experience

Apr 4, 2016

Targeted sequencing is currently the most promising and feasible path toward reliably uncovering common and rare variation in the human genome, both in terms of clinical feasibility and cost, when compared with whole-genome or whole-exome sequencing. Attributes such as automation, specificity and sensitivity can all have a critical impact on the overall sequencing quality and costs. RainDance offers a proven single-molecule picodroplet technology platform that allows researchers to apply the familiar gold-standard PCR technique more cost-effectively and at higher throughput than ever before using any next-generation sequencer. The streamlined workflow ensures highest quality sequence data and lowest overall cost per sample.

Application

Video

Related technologies: Digital PCR | Target enrichment for NGS

Brand profile

RainDance Technologies

RainDance company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases.

More info at:
www.raindancetech.com